array:19 [
  "pii" => "X0211699504029825"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2004-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2004;24 Supl 1:4"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2395
    "formatos" => array:3 [
      "EPUB" => 236
      "HTML" => 1675
      "PDF" => 484
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699504029817"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 14502
      "formatos" => array:3 [
        "EPUB" => 260
        "HTML" => 13409
        "PDF" => 833
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Aldosterona y función vascular en hipertensión"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "5"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E. CEDIEL , N. DE LAS HERAS , D. SANZ-ROSA , V. CACHOFEIRO , V. LAHERA , M. P. OUBIÑA , M. MIANA"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "E. CEDIEL , N. DE LAS HERAS , D. SANZ-ROSA , V. CACHOFEIRO , V. LAHERA , M. P. OUBIÑA , M. MIANA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029817?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029817/v0_201502091335/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699504029833"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2218
      "formatos" => array:3 [
        "EPUB" => 245
        "HTML" => 1569
        "PDF" => 404
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "¿Es el agente o el nivel de presión arterial lo que influye en la protección renal de las nefropatías crónicas?"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "3"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "F. LOCATELLI"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "F. LOCATELLI"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029833?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029833/v0_201502091335/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "NADPH Oxidación y stress oxidativo en las enfermedades cardiovasculares"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "4"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "R. A. CLARK , T. K. EPPERSON , J. VALENTE"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "R. A. CLARK , T. K. EPPERSON , J. VALENTE"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XXIV. Número Extraordinario (I). 2004 NADPH oxidación y stress oxidativo en las enfermedades cardiovasculares R. A. Clark, T. K. Epperson and A. J. Valente Department of Medicine. University of Texas Health Science Center. San Antonio. Texas. USA. The NADPH oxidase (NOX) gene family has been recently defined based on homology with the phagocyte respiratory burst oxidase, a well known multicomponent enzyme system that plays a critical role in antimicrobial host defenses. The essential components of the phagocyte oxidase (designated phox) include a membrane-bound flavo-heme catalytic subunit comprised of a gp91phox-p22phox heterodimer, as well as the cytosolic co-factors p47phox, p67phox, and the small GTPase Rac 1 or Rac 2. The gp91phox protein contains two heme groups associated with transmembrane segments, and binding sites in its cytoplasmic domains for FAD, NADPH, and the cytosolic co-factors. Stimulus-dependent assembly of the complete oxidase complex leads to catalyzed electron transport from cytosolic NADPH to molecular oxygen, producing the free radical superoxide anion ¯ (O2·). Superoxide then serves as an intermediate for the formation of other reactive oxygen species (ROS), such as hydrogen peroxide (H2O2) and hydroxyl radical (OH·). The NOX gene family has 5 members, all homologous to gp91phox, which is also designated NOX2. Although the members of the family exhibit structural similarity, they differ greatly in their range of tissue expression, co-factor and activation requirements, rate of superoxide formation, and apparent physiologic functions. For example, NOX1 is highly expressed in colon epithelium, NOX2 in phagocytes, and NOX4 in kidney. The preferred cytosolic co-factors for NOX1 are homologues of p47phox and p67phox, designated NOXO1 (O = organizer) and NOXA1 (A = activator), respectively. NOX5 has an N-terminal extension containing Ca2+-binding EFhand domains and is directly activated by calcium. EF-hand domains are also found in the NOX-related DUOX proteins, which in addition, have an extracellular peroxidase domain. The highest rates of superoxide formation are observed with the phagocyte oxidase, presumably due to the need to generate toxic concentrations of ROS for microbial killing, the main function of this NOX family member. A similar function has been postulated for NOX1 in colon cells. In contrast, other NOX family members appear to produce much lower superoxide fluxes, compatible with their putative roles in cell signaling. There is abundant evidence for the expression of NOX family members and co-factors in vascular tissues. Early studies focused on the phox system and generally concluded that all of its components are detected in endothelial, adventitial, and vascular smooth muscle cells, albeit at considerably lower levels than in phagocytes. More recent work has indicated that NOX4 is broadly expressed in vascular tissues and that NOX1 and NOX5 may be present, but are more restricted. The rate of superoxide formation by vascular NADPH oxidases is generally rather low, in keeping with a signaling function. Whether this is due strictly to low NOX protein expression levels or in part to differences in activation and regulation of catalytic function is unknown. Vascular NOX systems appear to be regulated under a variety of circumstances. For example, angiotensin II, which stimulates superoxide production in vascular cells, upregulates the expression of a number of NOX proteins and co-factors. Experimental evidence has implicated ROS generated by vascular NADPH oxidases in such highly prevalent diseases as atherosclerosis, hypertension, and diabetes. 4 "
    "pdfFichero" => "P7-E232-S132-A2963.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029825/v0_201502091335/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35393"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artículos Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000024000000S1/v0_201502091335/X0211699504029825/v0_201502091335/en/P7-E232-S132-A2963.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029825?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

NADPH Oxidación y stress oxidativo en las enfermedades cardiovasculares
R. A. CLARK , T. K. EPPERSON , J. VALENTE
Leído
6122
Veces
se ha leído el artículo
2188
Total PDF
3934
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X0211699504029825"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2004-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2004;24 Supl 1:4"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2395
    "formatos" => array:3 [
      "EPUB" => 236
      "HTML" => 1675
      "PDF" => 484
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699504029817"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 14502
      "formatos" => array:3 [
        "EPUB" => 260
        "HTML" => 13409
        "PDF" => 833
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Aldosterona y función vascular en hipertensión"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "5"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E. CEDIEL , N. DE LAS HERAS , D. SANZ-ROSA , V. CACHOFEIRO , V. LAHERA , M. P. OUBIÑA , M. MIANA"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "E. CEDIEL , N. DE LAS HERAS , D. SANZ-ROSA , V. CACHOFEIRO , V. LAHERA , M. P. OUBIÑA , M. MIANA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029817?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029817/v0_201502091335/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699504029833"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2004-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2004;24 Supl 1:3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2218
      "formatos" => array:3 [
        "EPUB" => 245
        "HTML" => 1569
        "PDF" => 404
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "¿Es el agente o el nivel de presión arterial lo que influye en la protección renal de las nefropatías crónicas?"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "3"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "F. LOCATELLI"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "F. LOCATELLI"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029833?idApp=UINPBA000064"
    "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029833/v0_201502091335/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "NADPH Oxidación y stress oxidativo en las enfermedades cardiovasculares"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "4"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "R. A. CLARK , T. K. EPPERSON , J. VALENTE"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "R. A. CLARK , T. K. EPPERSON , J. VALENTE"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XXIV. Número Extraordinario (I). 2004 NADPH oxidación y stress oxidativo en las enfermedades cardiovasculares R. A. Clark, T. K. Epperson and A. J. Valente Department of Medicine. University of Texas Health Science Center. San Antonio. Texas. USA. The NADPH oxidase (NOX) gene family has been recently defined based on homology with the phagocyte respiratory burst oxidase, a well known multicomponent enzyme system that plays a critical role in antimicrobial host defenses. The essential components of the phagocyte oxidase (designated phox) include a membrane-bound flavo-heme catalytic subunit comprised of a gp91phox-p22phox heterodimer, as well as the cytosolic co-factors p47phox, p67phox, and the small GTPase Rac 1 or Rac 2. The gp91phox protein contains two heme groups associated with transmembrane segments, and binding sites in its cytoplasmic domains for FAD, NADPH, and the cytosolic co-factors. Stimulus-dependent assembly of the complete oxidase complex leads to catalyzed electron transport from cytosolic NADPH to molecular oxygen, producing the free radical superoxide anion ¯ (O2·). Superoxide then serves as an intermediate for the formation of other reactive oxygen species (ROS), such as hydrogen peroxide (H2O2) and hydroxyl radical (OH·). The NOX gene family has 5 members, all homologous to gp91phox, which is also designated NOX2. Although the members of the family exhibit structural similarity, they differ greatly in their range of tissue expression, co-factor and activation requirements, rate of superoxide formation, and apparent physiologic functions. For example, NOX1 is highly expressed in colon epithelium, NOX2 in phagocytes, and NOX4 in kidney. The preferred cytosolic co-factors for NOX1 are homologues of p47phox and p67phox, designated NOXO1 (O = organizer) and NOXA1 (A = activator), respectively. NOX5 has an N-terminal extension containing Ca2+-binding EFhand domains and is directly activated by calcium. EF-hand domains are also found in the NOX-related DUOX proteins, which in addition, have an extracellular peroxidase domain. The highest rates of superoxide formation are observed with the phagocyte oxidase, presumably due to the need to generate toxic concentrations of ROS for microbial killing, the main function of this NOX family member. A similar function has been postulated for NOX1 in colon cells. In contrast, other NOX family members appear to produce much lower superoxide fluxes, compatible with their putative roles in cell signaling. There is abundant evidence for the expression of NOX family members and co-factors in vascular tissues. Early studies focused on the phox system and generally concluded that all of its components are detected in endothelial, adventitial, and vascular smooth muscle cells, albeit at considerably lower levels than in phagocytes. More recent work has indicated that NOX4 is broadly expressed in vascular tissues and that NOX1 and NOX5 may be present, but are more restricted. The rate of superoxide formation by vascular NADPH oxidases is generally rather low, in keeping with a signaling function. Whether this is due strictly to low NOX protein expression levels or in part to differences in activation and regulation of catalytic function is unknown. Vascular NOX systems appear to be regulated under a variety of circumstances. For example, angiotensin II, which stimulates superoxide production in vascular cells, upregulates the expression of a number of NOX proteins and co-factors. Experimental evidence has implicated ROS generated by vascular NADPH oxidases in such highly prevalent diseases as atherosclerosis, hypertension, and diabetes. 4 "
    "pdfFichero" => "P7-E232-S132-A2963.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000024000000S1/v0_201502091335/X0211699504029825/v0_201502091335/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35393"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artículos Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000024000000S1/v0_201502091335/X0211699504029825/v0_201502091335/en/P7-E232-S132-A2963.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699504029825?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 9 11 20
2024 Octubre 60 38 98
2024 Septiembre 53 26 79
2024 Agosto 63 75 138
2024 Julio 36 22 58
2024 Junio 44 37 81
2024 Mayo 66 34 100
2024 Abril 50 36 86
2024 Marzo 29 21 50
2024 Febrero 43 40 83
2024 Enero 27 26 53
2023 Diciembre 20 29 49
2023 Noviembre 48 33 81
2023 Octubre 53 45 98
2023 Septiembre 73 28 101
2023 Agosto 57 23 80
2023 Julio 56 29 85
2023 Junio 42 25 67
2023 Mayo 53 32 85
2023 Abril 34 13 47
2023 Marzo 22 19 41
2023 Febrero 23 24 47
2023 Enero 35 32 67
2022 Diciembre 37 36 73
2022 Noviembre 51 22 73
2022 Octubre 47 47 94
2022 Septiembre 53 31 84
2022 Agosto 38 50 88
2022 Julio 34 49 83
2022 Junio 37 35 72
2022 Mayo 35 33 68
2022 Abril 34 57 91
2022 Marzo 24 37 61
2022 Febrero 27 26 53
2022 Enero 30 31 61
2021 Diciembre 32 40 72
2021 Noviembre 29 35 64
2021 Octubre 40 40 80
2021 Septiembre 22 37 59
2021 Agosto 27 38 65
2021 Julio 22 33 55
2021 Junio 17 24 41
2021 Mayo 28 40 68
2021 Abril 98 61 159
2021 Marzo 78 30 108
2021 Febrero 56 22 78
2021 Enero 36 19 55
2020 Diciembre 26 10 36
2020 Noviembre 18 11 29
2020 Octubre 25 16 41
2020 Septiembre 19 8 27
2020 Agosto 26 5 31
2020 Julio 35 13 48
2020 Junio 36 16 52
2020 Mayo 45 15 60
2020 Abril 36 15 51
2020 Marzo 38 12 50
2020 Febrero 54 16 70
2020 Enero 46 22 68
2019 Diciembre 33 29 62
2019 Noviembre 37 14 51
2019 Octubre 20 12 32
2019 Septiembre 38 17 55
2019 Agosto 16 15 31
2019 Julio 23 25 48
2019 Junio 27 18 45
2019 Mayo 24 21 45
2019 Abril 71 34 105
2019 Marzo 21 22 43
2019 Febrero 15 14 29
2019 Enero 6 16 22
2018 Diciembre 36 29 65
2018 Noviembre 36 11 47
2018 Octubre 44 14 58
2018 Septiembre 30 12 42
2018 Agosto 19 9 28
2018 Julio 20 15 35
2018 Junio 21 5 26
2018 Mayo 18 9 27
2018 Abril 23 7 30
2018 Marzo 21 7 28
2018 Febrero 21 8 29
2018 Enero 16 5 21
2017 Diciembre 21 7 28
2017 Noviembre 11 5 16
2017 Octubre 15 3 18
2017 Septiembre 9 6 15
2017 Agosto 15 3 18
2017 Julio 16 7 23
2017 Junio 9 3 12
2017 Mayo 14 3 17
2017 Abril 14 5 19
2017 Marzo 15 5 20
2017 Febrero 8 4 12
2017 Enero 6 5 11
2016 Diciembre 6 5 11
2016 Noviembre 17 7 24
2016 Octubre 10 11 21
2016 Septiembre 40 3 43
2016 Agosto 70 5 75
2016 Julio 54 3 57
2016 Junio 57 0 57
2016 Mayo 84 0 84
2016 Abril 43 0 43
2016 Marzo 54 0 54
2016 Febrero 46 0 46
2016 Enero 53 0 53
2015 Diciembre 61 0 61
2015 Noviembre 45 0 45
2015 Octubre 36 0 36
2015 Septiembre 34 0 34
2015 Agosto 40 0 40
2015 Julio 27 0 27
2015 Junio 12 0 12
2015 Mayo 17 0 17
2015 Abril 7 0 7
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?